Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness

NCT02057757 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

260

Enrollment

NIH

Sponsor class

Conditions

Severe Acute Respiratory Illness

Interventions

DRUG: Nitazoxanide
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]